Immix Biopharma, Inc. IMMX Proceeds From Sale Of Short Term Investments
Proceeds From Sale Of Short Term Investments at other companies
Other financials
Where this comes from
Reported directly by Immix Biopharma, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromSaleOfShortTermInvestments.
The official record: Immix Biopharma, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immix Biopharma, Inc.'s proceeds from sale of short term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Immix Biopharma, Inc.'s proceeds from sale of short term investments?
- Immix Biopharma, Inc. (IMMX) reported proceeds from sale of short term investments of $3M in Q1 2026.